Representatives sign Memorandum of Intent. Durham, July, 3rd, 2007.
Under the terms of this Memorandum, Dr. Patterson will act as an advisor in the installation of key technologies and laboratory service and the technical operation of the laboratory, while Thrombotargets will be responsible for installation of its proprietary technologies, laboratory design and build out, management of the corporation and laboratory, and the lab’s new drug discovery services sales and marketing activities.
It is anticipated that this new laboratory will be fully operational by the first quarter of 2008.
“This Memorandum executed between Thrombotargets and Dr. Patterson, not only represents an agreement to create an important business venture in the US, it will lead to a very important business and scientific relationship with the Carolina Cardiovascular Biology Center”.explained Steven A. Hite, Thrombotargets’ COO.
“Today we have taken the first step towards the global commercialization of CCBC techniques and models,” stated Dr. Patterson, MD, FACC, and Director of the CCBC “The combination of our unique, proprietary technologies in forming this CRO represents the first of its kind in the industry with the capability to streamline and greatly improve the new drug discovery process.
About Thrombotargets
Thrombotargets (www.thrombotargets.com) is a privately held group of biotech companies focused on the discovery and development of innovative drugs in Haemostasis, Thrombosis and Atherosclerosis. The company has a number of potential new drugs in development internally, and its proprietary targets and innovative uHTS platforms are used in internal drug discovery programs, and are also available for client drug discovery projects.
About CCBC
The Carolina Cardiovascular Biology Center, established in 2000, is a multidisciplinary, multidepartmental facility that serves as a focal point for interactions among basic, translational, and clinical scientists studying all aspects of cardiovascular disease. Areas of specific interest include atherosclerosis and other vascular diseases, angiogenesis and cardiovascular development, cardiovascular physiology, and diseases of hemostasis.
Mansi Gupta Recommends that you visit www.thrombotargets.com for more information on thrombotargets and thrombotarget .